Global Markets for Fermentation Ingredients to Reach $53.4 Billion by 2031, Driven by Rising Demand for Animal Nutrition Ingredients

“The global market is forecast to grow from $39.8 billion in 2026 to $53.4 billion by 2031 at a 6.1% CAGR as animal nutrition, pharmaceuticals and sustainable bio-based production drive demand for amino acids, enzymes, organic acids and vitamins.”

Boston, Aug. 31, 2026 (GLOBE NEWSWIRE) -- The global market for fermentation ingredients is projected to grow from $39.8 billion in 2026 to $53.4 billion by 2031, at a compound annual growth rate (CAGR) of 6.1% over the forecast period. This growth trajectory is detailed in BCC Research's latest report, Global Markets for Fermentation Ingredients, which identifies structural demand across animal nutrition, pharmaceuticals, food fortification, and industrial biotechnology as the principal forces reshaping the competitive landscape.

Key Findings

• Market size and growth: The global fermentation ingredients market is valued at $39.8 billion in 2026 and is forecast to reach $53.4 billion by 2031, expanding at a 6.1% CAGR. Long-term growth is anchored by the expanding global livestock, poultry, swine, and aquaculture industries, which increasingly rely on fermentation-derived amino acids — including lysine, threonine, and tryptophan — alongside enzymes and vitamins to improve feed conversion efficiency and production sustainability.
• Largest region: Asia Pacific accounts for 38.4% of the global market, underpinned by the region's dominant role in fermentation-derived fine chemical manufacturing, large-scale animal feed production, and growing pharmaceutical API output — though supply chain concentration in China simultaneously represents both a competitive advantage and a systemic risk.
• Pharmaceutical reshoring: Governments across the U.S., Europe, and India are actively investing in domestic fermentation and API manufacturing infrastructure to reduce dependence on Asia-concentrated supply chains. Production Linked Incentive (PLI) schemes in India explicitly target fermentation-derived pharmaceuticals, including Penicillin G and antibiotic intermediates, directly stimulating capacity investment and sustained long-term demand.
• Sustainability mandates and bio-based adoption: Global ESG commitments and circular-economy mandates are accelerating the substitution of petrochemical-derived intermediates with fermentation-based alternatives such as succinic acid, itaconic acid, and lactic acid. Simultaneously, enzyme adoption in detergent formulations — enabling low-temperature cleaning and reduced energy consumption — is expanding across textiles, biofuels, and specialty industrial processing.
• Emerging technologies: Precision fermentation, synthetic biology and microbial strain engineering, and AI-assisted enzyme design represent the most consequential near-term disruptors. Second-generation biomass fermentation and fermentation-derived bio-based polymers and materials are expanding the addressable market well beyond traditional food and feed applications.
• Competitive landscape: The market features a diversified set of global leaders including BASF SE, dsm-firmenich, Ajinomoto Co. Inc., Novonesis, Evonik Industries AG, Cargill Inc., Roquette Frères, CJ CheilJedang Corp., Lonza Group, Corbion, Lesaffre International, ADM, Angel Yeast Co. Ltd., Kerry Group, and Merck KGaA, among others.

Market Drivers

The fermentation ingredients market is supported by a convergence of structural forces that extend well beyond cyclical demand patterns. The global animal nutrition sector remains the largest application segment, with feed manufacturers increasingly specifying fermentation-derived amino acids, phytases, and proteases as essential inputs — a demand profile reinforced by regulatory pressure on antibiotic use in livestock and a broader industry shift toward precision nutrition.
In parallel, pharmaceutical supply chain security has become a strategic priority across Western markets following pandemic-era disruptions. Government incentive programs and domestic manufacturing mandates in the U.S., Europe, and India are creating durable demand for industrial fermentation infrastructure. Consumer-driven tailwinds — including aging populations, rising prevalence of nutrient deficiencies, and expanding interest in functional foods — are reinforcing growth in fermentation-derived vitamins, probiotics, and fortified food ingredients, broadening the revenue base across multiple end-use verticals.

Investment Considerations

Investors evaluating the fermentation ingredients sector should weigh compelling structural upside against a set of well-defined operational risks. High capital costs — with commercial-scale fermentation facilities estimated at three to four times the cost of equivalent petrochemical plants — create meaningful barriers to entry that favor established players with existing bioreactor infrastructure and downstream processing capabilities. Geopolitical concentration risk remains material, given the global supply chain's continued dependence on China for amino acids, vitamins, and biochemical intermediates. Volatile feedstock pricing tied to corn starch, molasses, and glucose syrups presents an ongoing margin management challenge. Best-positioned companies are those with diversified geographic manufacturing footprints, vertically integrated fermentation platforms, and active investment in precision fermentation and synthetic biology capabilities — characteristics evident across leaders including dsm-firmenich, Ajinomoto Co. Inc., Novonesis, Evonik Industries AG, and Lonza Group.

About the Report

Global Markets for Fermentation Ingredients provides comprehensive market sizing, application and regional segmentation, competitive intelligence, and forecasts spanning 2026 to 2031.

About BCC Research

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth trends, identify and evaluate new and changing market opportunities, and provide critical information and innovative decision support tools to help inform the strategic decision-making process.
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

BCC Research LLC
50 Milk St., Ste. 16, Boston, MA 02109
press@bccresearch.com  |  +1 781-489-7301
www.bccresearch.com